M. Inanç Et Al. , "Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome," British Journal of Rheumatology , vol.37, no.10, pp.1089-1094, 1998
Inanç, M. Et Al. 1998. Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. British Journal of Rheumatology , vol.37, no.10 , 1089-1094.
Inanç, M., DONOHOE, S., RAVIRAJAN, C., RADWAY-BRIGHT, E., MACKIE, I., MACHIN, S., ... ISENBERG, D.(1998). Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. British Journal of Rheumatology , vol.37, no.10, 1089-1094.
Inanç, Murat Et Al. "Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome," British Journal of Rheumatology , vol.37, no.10, 1089-1094, 1998
Inanç, Murat Et Al. "Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome." British Journal of Rheumatology , vol.37, no.10, pp.1089-1094, 1998
Inanç, M. Et Al. (1998) . "Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome." British Journal of Rheumatology , vol.37, no.10, pp.1089-1094.
@article{article, author={Murat İNANÇ Et Al. }, title={Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome}, journal={British Journal of Rheumatology}, year=1998, pages={1089-1094} }